Skip to main content
RIGL logo

RIGL · Rigel Pharmaceuticals Inc · Investor Relations

Track RIGL — free
$42.53 -0.39 (-0.91%) At close · Nov 18 Play latest call Q3 2026 earnings call transcript
Market Cap
$800.84M
Shares
18.83M
Volume · Nov 18 304.84K Avg daily vol (3M) 252.93K

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Past events

Date Event Type
2026-11-17 Jefferies Global Healthcare Conference in London Conference
2026-11-17 Jefferies Global Healthcare Conference Conference
2026-11-05 Third Quarter 2026 Financial Results Earnings call
2026-11-05 November 2026 Corporate Presentation Presentation
2026-09-15 H.C. Wainwright 28th Annual Global Investment Conference Conference
2026-09-10 Cantor Global Healthcare Conference 2026 Conference
2026-08-13 August 2026 Corporate Presentation Presentation
2026-08-04 Second Quarter 2026 Financial Results Results publication
2026-08-04 Q2 FY2026 Earnings conference call (announced in 8-K) Earnings call
2026-08-04 August 2026 Corporate Presentation Presentation
2026-06-16 June 2026 Corporate Presentation Presentation
2026-06-03 Jefferies Global Healthcare Conference Conference
2026-05-19 2026 RBC Capital Markets Global Healthcare Conference Conference
2026-05-14 2026 Annual Meeting of Stockholders Shareholder meeting
2026-05-12 Rigel Pharmaceuticals, Inc. VEPPANU (vepdegestrant) Licensing Agreement Conference Call Conference
2026-05-05 Q1 FY2026 Earnings conference call (announced in 8-K) Earnings call
2026-03-03 Earnings conference call (announced in 8-K) Earnings call

Source: https://www.rigel.com/investors

Key facts CIK 1034842 CUSIP 766559702 13F (30d) 182 filings 156 filers Visit website Investor relations